Warren, R., Sofen, H., Imafuku, S., Szepietowski, J., Blauvelt, A., Spelman, L., Toms, J., Buck, A., Banerjee, S., & Menter, A. (2022). Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, 6(6), s48. https://doi.org/10.25251/skin.6.supp.48